<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03593239</url>
  </required_header>
  <id_info>
    <org_study_id>PROT-00008 / v2.1</org_study_id>
    <nct_id>NCT03593239</nct_id>
  </id_info>
  <brief_title>Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers</brief_title>
  <official_title>A Ten Sequence, Open Label, Randomized Crossover Study Comparing Nicotine Pharmacokinetics of JUUL 1.7% and JUUL 5% Nicotine Salt Based Electronic Nicotine Delivery System (ENDS Products), in Healthy Adult Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Juul Labs, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Juul Labs, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Ten Sequence, Open Label, Randomized Crossover Study Comparing Nicotine Pharmacokinetics of
      JUUL 1.7% and JUUL 5% Nicotine Salt Based ENDS Products, in Healthy Adult Smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      E-cigarettes may be an acceptable alternative to traditional cigarette smoking. In utilizing
      vaporization rather than combustion, the generation and inhalation of smoke and carbon
      monoxide (CO) may be reduced or avoided. JUUL has developed several nicotine based liquid
      blends for use in e-cigarettes. This study will provide an understanding of the levels of
      nicotine obtained with use of the company's 1.7% and 5% ENDS products.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 29, 2018</start_date>
  <completion_date type="Actual">July 26, 2018</completion_date>
  <primary_completion_date type="Actual">July 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare nicotine pharmacokinetics(PK) in smokers and e-cigarette users measuring Time to Maximum Concentration(Tmax)</measure>
    <time_frame>38 Days</time_frame>
    <description>Compare nicotine pharmacokinetics (PK) in smokers and e-cigarette users, obtained with:
Tobacco flavored JUUL 1.7% ENDS (10 puffs); Tobacco flavored JUUL 5% ENDS (10 puffs); Mint flavored JUUL 1.7% ENDS (10 puffs); Mint flavored JUUL 5% ENDS (10 puffs); Fruit Medley flavored JUUL 1.7% ENDS (10 puffs); Fruit Medley flavored JUUL 5% ENDS (10 puffs); Crème brulee flavored JUUL 1.7% ENDS (10 puffs); Crème brulee flavored JUUL 5% ENDS (10 puffs).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare nicotine pharmacokinetics(PK) in smokers and e-cigarette users measuring Concentration Maximum (Cmax)</measure>
    <time_frame>38 Days</time_frame>
    <description>Compare nicotine pharmacokinetics (PK) in smokers and e-cigarette users, obtained with:
Tobacco flavored JUUL 1.7% ENDS (10 puffs); Tobacco flavored JUUL 5% ENDS (10 puffs); Mint flavored JUUL 1.7% ENDS (10 puffs); Mint flavored JUUL 5% ENDS (10 puffs); Fruit Medley flavored JUUL 1.7% ENDS (10 puffs); Fruit Medley flavored JUUL 5% ENDS (10 puffs); Crème brulee flavored JUUL 1.7% ENDS (10 puffs); Crème brulee flavored JUUL 5% ENDS (10 puffs).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare nicotine pharmacokinetics(PK) in smokers and e-cigarette users measuring Cmax-baseline and Area Under the Curve ( AUC) 1hour</measure>
    <time_frame>38 Days</time_frame>
    <description>Compare nicotine pharmacokinetics (PK) in smokers and e-cigarette users, obtained with:
Tobacco flavored JUUL 1.7% ENDS (10 puffs); Tobacco flavored JUUL 5% ENDS (10 puffs); Mint flavored JUUL 1.7% ENDS (10 puffs); Mint flavored JUUL 5% ENDS (10 puffs); Fruit Medley flavored JUUL 1.7% ENDS (10 puffs); Fruit Medley flavored JUUL 5% ENDS (10 puffs); Crème brulee flavored JUUL 1.7% ENDS (10 puffs); Crème brulee flavored JUUL 5% ENDS (10 puffs).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare nicotine pharmacokinetics(PK) in smokers and e-cigarette users measuring AUC1hour-baseline of nicotine</measure>
    <time_frame>38 Days</time_frame>
    <description>Compare nicotine pharmacokinetics (PK) in smokers and e-cigarette users, obtained with:
Tobacco flavored JUUL 1.7% ENDS (10 puffs); Tobacco flavored JUUL 5% ENDS (10 puffs); Mint flavored JUUL 1.7% ENDS (10 puffs); Mint flavored JUUL 5% ENDS (10 puffs); Fruit Medley flavored JUUL 1.7% ENDS (10 puffs); Fruit Medley flavored JUUL 5% ENDS (10 puffs); Crème brulee flavored JUUL 1.7% ENDS (10 puffs); Crème brulee flavored JUUL 5% ENDS (10 puffs).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Pre and Post exhaled carbon monoxide (CO) values for each subject and Test Product.</measure>
    <time_frame>38 Days</time_frame>
    <description>Change in Pre and Post exhaled carbon monoxide (CO) values for each subject and Test Product.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare user satisfaction measures of each Test Product when consumed by smokers and e-cigarette users.</measure>
    <time_frame>38 Days</time_frame>
    <description>Measure of subjective product evaluation using the &quot;modified Product Evaluation Scale (mPES)&quot; Change in Evaluation; Scale: 1 = not at all, 2 = very little, 3 = a little, 4 = moderately, 5 = a lot, 6 = quite a lot, 7 = extremely
Four multi-item subscales will be derived from &quot;Satisfaction&quot; (items 1, 2, 3, and 12); &quot;Psychological Reward&quot; (items 4 through 8); &quot;Aversion&quot; (items 9, 10, 16, and 18); and &quot;Relief&quot; (item 11, 13, 14, 15, and reversed for item 19) and single items 17 and 20 will be summarized.</description>
  </secondary_outcome>
  <number_of_arms>10</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Nicotine Dependence</condition>
  <condition>Nicotine Dependence, Cigarettes</condition>
  <condition>Tobacco Use</condition>
  <condition>Tobacco Smoking</condition>
  <arm_group>
    <arm_group_label>Tobacco flavored JUUL 1.7% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tobacco flavored JUUL 1.7% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tobacco flavored JUUL 5% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tobacco flavored JUUL 5% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mint flavored JUUL 1.7% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mint flavored JUUL 1.7% ENDS (10 puffs);</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mint flavored JUUL 5% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mint flavored JUUL 5% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fruit Medley flavored JUUL 1.7% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fruit Medley flavored JUUL 1.7% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fruit Medley flavored JUUL 5% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fruit Medley flavored JUUL 5% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crème brulee flavored JUUL 1.7% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Crème brulee flavored JUUL 1.7% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crème brulee flavored JUUL 5% ENDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Crème brulee flavored JUUL 5% ENDS (10 puffs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>JUUL 1.7% ENDS 10 puffs vs. ad lib puffs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tobacco flavoured JUUL 1.7% ENDS products 10 puffs versus ad libitum puffs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>JUUL 5% ENDS 10 puffs vs. ad lib puffs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tobacco flavoured JUUL 5% ENDS products 10 puffs versus ad libitum puffs</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tobacco flavored JUUL 1.7% ENDS</intervention_name>
    <description>Treatment with Tobacco flavored JUUL 1.7% ENDS (10 puffs)</description>
    <arm_group_label>Tobacco flavored JUUL 1.7% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tobacco flavored JUUL 5% ENDS</intervention_name>
    <description>Treatment with Tobacco flavored JUUL 5% ENDS(10 puffs)</description>
    <arm_group_label>Tobacco flavored JUUL 5% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mint flavored JUUL 1.7% ENDS</intervention_name>
    <description>Treatment with Mint flavored JUUL 1.7% ENDS(10 puffs)</description>
    <arm_group_label>Mint flavored JUUL 1.7% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mint flavored JUUL 5% ENDS</intervention_name>
    <description>Treatment with Mint flavored JUUL 5% ENDS(10 puffs)</description>
    <arm_group_label>Mint flavored JUUL 5% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fruit Medley flavored JUUL 1.7% ENDS</intervention_name>
    <description>Treatment with Fruit Medley flavored JUUL 1.7% ENDS(10 puffs)</description>
    <arm_group_label>Fruit Medley flavored JUUL 1.7% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fruit Medley flavored JUUL 5% ENDS</intervention_name>
    <description>Treatment with Fruit Medley flavored JUUL 5% ENDS(10 puffs)</description>
    <arm_group_label>Fruit Medley flavored JUUL 5% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Crème brulee flavored JUUL 1.7% ENDS</intervention_name>
    <description>Treatment with Crème brulee flavored JUUL 1.7% ENDS(10 puffs)</description>
    <arm_group_label>Crème brulee flavored JUUL 1.7% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Crème brulee flavored JUUL 5% ENDS</intervention_name>
    <description>Treatment with Crème brulee flavored JUUL 5% ENDS(10 puffs)</description>
    <arm_group_label>Crème brulee flavored JUUL 5% ENDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>JUUL 1.7% ENDS 10 puffs vs. ad lib puffs</intervention_name>
    <description>Treatment with JUUL 1.7% ENDS 10 puffs vs. ad libitum puffs</description>
    <arm_group_label>JUUL 1.7% ENDS 10 puffs vs. ad lib puffs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>JUUL 5% ENDS 10 puffs vs. ad lib puffs</intervention_name>
    <description>Treatment with JUUL 5% ENDS 10 puffs vs. ad libitum puffs</description>
    <arm_group_label>JUUL 5% ENDS 10 puffs vs. ad lib puffs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged 18 to 60 years of age inclusive.

          -  Current smoker or e-cigarette user:

          -  Able to participate, and willing to give written informed consent and to comply with
             the ° study restrictions.

        Exclusion criteria:

          -  Clinically significant abnormality on screening ECG.

          -  Sustained blood pressure recordings at screening of &lt; 90 mmHg or &gt; 150 mmHg for
             systolic blood pressure, or &lt; 50 mmHg or &gt; 90 mmHg for diastolic blood pressure.

          -  Sustained resting heart rate of &gt; 100 or &lt; 40 beats per minute at screening.

          -  Positive result for urine drugs of abuse test or alcohol breath test at screening.

          -  Clinically significant abnormality in laboratory test results at screening, in the
             opinion of the Investigator.

          -  Positive urine pregnancy test at screening or Assessment Days in female subjects of
             child bearing potential.

          -  Any clinically significant concomitant disease or conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Christchurch Clinical Studies Trust Ltd</name>
      <address>
        <city>Christchurch</city>
        <zip>8011</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>June 1, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2018</study_first_posted>
  <last_update_submitted>January 8, 2019</last_update_submitted>
  <last_update_submitted_qc>January 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electronic Nicotine Delivery System</keyword>
  <keyword>Combustible Cigarettes</keyword>
  <keyword>Nicotine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

